Jennifer Marie Mataraza

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody molecules to PD-1 and uses thereof
- Patent number 11,827,704
- Issue date Nov 28, 2023
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 11,413,340
- Issue date Aug 16, 2022
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of detecting TIM-3 using antibody molecules to TIM-3
- Patent number 11,155,620
- Issue date Oct 26, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,981,990
- Issue date Apr 20, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Grant
Antibody molecules to PD-L1 and methods of treating cancer
- Patent number 10,851,165
- Issue date Dec 1, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to PD-1 and uses thereof
- Patent number 10,752,687
- Issue date Aug 25, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to LAG-3 and uses thereof
- Patent number 10,711,060
- Issue date Jul 14, 2020
- Novartis AG
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,472,419
- Issue date Nov 12, 2019
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fully human antibodies to BTLA
- Patent number 10,155,813
- Issue date Dec 18, 2018
- E.R. Squibb & Sons, L.L.C.
- Jennifer Marie Mataraza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to PD-L1 and uses thereof
- Patent number 9,988,452
- Issue date Jun 5, 2018
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to LAG-3 and uses thereof
- Patent number 9,908,936
- Issue date Mar 6, 2018
- Novartis AG
- Frédéric Triebel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 9,884,913
- Issue date Feb 6, 2018
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to PD-1 and uses thereof
- Patent number 9,815,898
- Issue date Nov 14, 2017
- Novartis AG
- Gordon James Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to PD-1 and uses thereof
- Patent number 9,683,048
- Issue date Jun 20, 2017
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 9,605,070
- Issue date Mar 28, 2017
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human antibodies to BTLA
- Patent number 9,346,882
- Issue date May 24, 2016
- E.R. Squibb & Sons, L.L.C.
- Jennifer Marie Mataraza
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fully human antibodies to BTLA
- Patent number 8,563,694
- Issue date Oct 22, 2013
- Medarex, Inc.
- Jennifer Marie Mataraza
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...
- Publication number 20240343808
- Publication date Oct 17, 2024
- Novartis AG
- Gordon James Freeman
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1
- Publication number 20230013364
- Publication date Jan 19, 2023
- Novartis AG
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...
- Publication number 20230000964
- Publication date Jan 5, 2023
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220185883
- Publication date Jun 16, 2022
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
- Publication number 20220153835
- Publication date May 19, 2022
- Novartis AG
- Glenn DRANOFF
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220133889
- Publication date May 5, 2022
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
- Publication number 20210284737
- Publication date Sep 16, 2021
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20210009687
- Publication date Jan 14, 2021
- Novartis AG
- Frédéric Triebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20200339689
- Publication date Oct 29, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200308277
- Publication date Oct 1, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES
- Publication number 20200277378
- Publication date Sep 3, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200223917
- Publication date Jul 16, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FULLY HUMAN ANTIBODIES TO BTLA
- Publication number 20190119381
- Publication date Apr 25, 2019
- E. R. SQUIBB & SONS, L.L.C.
- Jennifer Marie MATARAZA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...
- Publication number 20190000944
- Publication date Jan 3, 2019
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
- Publication number 20180340025
- Publication date Nov 29, 2018
- Novartis AG
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1
- Publication number 20180222982
- Publication date Aug 9, 2018
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20180207273
- Publication date Jul 26, 2018
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
- Publication number 20180186882
- Publication date Jul 5, 2018
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20180155427
- Publication date Jun 7, 2018
- Novartis AG
- Gordon James Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20180086830
- Publication date Mar 29, 2018
- Novartis AG
- Frédéric Triebel
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20170247456
- Publication date Aug 31, 2017
- Novartis AG
- Gordon James Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20170210804
- Publication date Jul 27, 2017
- Novartis AG
- Frédéric Triebel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20170198041
- Publication date Jul 13, 2017
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20170190777
- Publication date Jul 6, 2017
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FULLY HUMAN ANTIBODIES TO BTLA
- Publication number 20160222114
- Publication date Aug 4, 2016
- E. R. SQUIBB & SONS, L.L.C.
- Jennifer Marie MATARAZA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
- Publication number 20160108123
- Publication date Apr 21, 2016
- Novartis AG
- Gordon James Freeman
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
- Publication number 20150259420
- Publication date Sep 17, 2015
- Novartis AG
- Frédéric Triebel
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20150218274
- Publication date Aug 6, 2015
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20150210769
- Publication date Jul 30, 2015
- Novartis AG
- Gordon James Freeman
- G01 - MEASURING TESTING
Information Patent Application
FULLY HUMAN ANTIBODIES TO BTLA
- Publication number 20140017255
- Publication date Jan 16, 2014
- MEDAREX, L.L.C.
- Jennifer Marie MATARAZA
- C07 - ORGANIC CHEMISTRY

Jennifer Marie Mataraza

Person

Patents Grantslast 30 patents

Antibody molecules to PD-1 and uses thereof

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

Method of detecting TIM-3 using antibody molecules to TIM-3

Antibody molecules to TIM-3 and uses thereof

Antibody molecules to PD-L1 and methods of treating cancer

Antibody molecules to PD-1 and uses thereof

Antibody molecules to LAG-3 and uses thereof

Antibody molecules to TIM-3 and uses thereof

Fully human antibodies to BTLA

Antibody molecules to PD-L1 and uses thereof

Antibody molecules to LAG-3 and uses thereof

Antibody molecules to TIM-3 and uses thereof

Antibody molecules to PD-1 and uses thereof

Antibody molecules to PD-1 and uses thereof

Antibody molecules to TIM-3 and uses thereof

Fully human antibodies to BTLA

Fully human antibodies to BTLA

Patents Applicationslast 30 patents

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1

MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

COMBINATION THERAPIES

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

FULLY HUMAN ANTIBODIES TO BTLA

MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

FULLY HUMAN ANTIBODIES TO BTLA

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

FULLY HUMAN ANTIBODIES TO BTLA